The GENIE Registry is a continuously evolving, publicly available real-world data resource, housing:
By the Numbers
- 230,000+ clinical-grade genomic samples from 200,000+ patients
- 30,000 new patients added annually
- High-fidelity clinico-genomic data from academic tertiary referral centers
- International representation (U.S. & ex-U.S. patient populations)
Why It Matters
The breadth and quality of GENIE data make it an essential resource for:
- Biomarker Discovery – Identifying and validating predictive biomarkers.
- Clinical Trial Feasibility – Informing trial design and patient selection.
- Regulatory-Grade RWE – Supporting real-world evidence (RWE) submissions.
Unlike commercial datasets primarily sourced from community practices, the GENIE Registry reflects real-world clinical practice at leading academic cancer centers, ensuring data quality, diversity, and regulatory relevance.